Article
Genome-wide association study reveals a complex genetic architecture underpinning-induced CYP3A4 enzyme activity.
European journal of drug metabolism and pharmacokinetics - 1 Mar 2013
Rahmioglu Nilufer, Heaton James, Clement Gail, Gill Raj, Surdulescu Gabriela, Zlobecka Karolina, Hodgkiss Dylan, Smith Norman W, Ahmadi Kourosh R
Abstract excerpt
Atypical cytochrome P450 3A4 (CYP3A4) enzyme activity-induced and inhibited-is thought to be the driver of numerous poor or adverse therapeutic responses to up to 50 % of all commonly prescribed drugs. We carried out a genome-wide association study to identify common genetic variants associated w...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
